论文部分内容阅读
本文分析了我院放疗科从1975年1月～1981年12月7年间收治的54例扁桃体癌患者放射治疗的临床资料与生存率的关系,其五年生存率为44.4％。影响生存率的主要因素是病期和肿瘤控制率。因此,早期发现、早期诊断、早期治疗此病对于提高生存率是十分重要的。我们推荐的剂量以6000～7000cGY/6～7周为宜,对晚期病例,适当的缩野追加可望获得较好的肿瘤控制率。在有条件的情况下,辅以X一线口腔筒照射等可望达到控制肿瘤、提高生存率的目的。
This article analyzes the relationship between the clinical data and survival rate of 54 patients with tonsil cancer treated in radiotherapy department in our hospital from January 1975 to December 1981. The five-year survival rate is 44.4%. The main factors affecting the survival rate are the disease period and the rate of tumor control. Therefore, early detection, early diagnosis, and early treatment of the disease are very important for improving survival. The recommended dose is 6000 to 7000 cGy/6 to 7 weeks. For advanced cases, the appropriate shrinkage field is expected to achieve a better rate of tumor control. Under conditional conditions, supplemented with X-ray tube irradiation is expected to achieve the purpose of controlling tumors and improving survival.